281 related articles for article (PubMed ID: 27342912)
21. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus.
Chong JM; Fukayama M; Hayashi Y; Funata N; Takizawa T; Koike M; Muraoka M; Kikuchi-Yanoshita R; Miyaki M; Mizuno S
Int J Cancer; 1997 Aug; 74(4):450-4. PubMed ID: 9291438
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
[TBL] [Abstract][Full Text] [Related]
23. Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases.
van Beek J; zur Hausen A; Snel SN; Berkhof J; Kranenbarg EK; van de Velde CJ; van den Brule AJ; Middeldorp JM; Meijer CJ; Bloemena E
Am J Surg Pathol; 2006 Jan; 30(1):59-65. PubMed ID: 16330943
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.
Kang BW; Seo AN; Yoon S; Bae HI; Jeon SW; Kwon OK; Chung HY; Yu W; Kang H; Kim JG
Ann Oncol; 2016 Mar; 27(3):494-501. PubMed ID: 26673353
[TBL] [Abstract][Full Text] [Related]
25. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
Zhao P; Lu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis.
Tokunaga M; Land CE
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):449-50. PubMed ID: 9610796
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma.
Li S; Du H; Wang Z; Zhou L; Zhao X; Zeng Y
Sci China Life Sci; 2010 Apr; 53(4):524-30. PubMed ID: 20596921
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas.
Sugimoto M; Mitsunaga S; Yoshikawa K; Kato Y; Gotohda N; Takahashi S; Konishi M; Ikeda M; Kojima M; Ochiai A; Kaneko H
Eur J Cancer; 2014 Jul; 50(11):1900-8. PubMed ID: 24835032
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
[TBL] [Abstract][Full Text] [Related]
30. Correlation Between Infection Status of Epstein-Barr Virus and
Na SJ; Park HL; O JH; Lee SY; Song KY; Kim SH
In Vivo; 2017; 31(4):749-753. PubMed ID: 28652452
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
32. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
[TBL] [Abstract][Full Text] [Related]
34. CT appearance of Epstein-Barr virus-associated gastric carcinoma.
Maeda E; Akahane M; Uozaki H; Kato N; Hayashi N; Fukayama M; Ohtomo K
Abdom Imaging; 2009; 34(5):618-25. PubMed ID: 18668190
[TBL] [Abstract][Full Text] [Related]
35. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in Epstein-Barr virus-associated stage I-III gastric carcinoma: implications for a unique type of carcinogenesis.
Huang SC; Ng KF; Chen KH; Hsu JT; Liu KH; Yeh TS; Chen TC
Oncol Rep; 2014 Aug; 32(2):530-8. PubMed ID: 24899228
[TBL] [Abstract][Full Text] [Related]
37. Implication of Leptin-Signaling Proteins and Epstein-Barr Virus in Gastric Carcinomas.
Choi E; Byeon SJ; Kim SH; Lee HJ; Kwon HJ; Ahn H; Kim DH; Chang MS
PLoS One; 2015; 10(7):e0130839. PubMed ID: 26147886
[TBL] [Abstract][Full Text] [Related]
38. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.
Chiaravalli AM; Feltri M; Bertolini V; Bagnoli E; Furlan D; Cerutti R; Novario R; Capella C
Virchows Arch; 2006 Mar; 448(3):344-53. PubMed ID: 16261379
[TBL] [Abstract][Full Text] [Related]
39. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.
Ohtaki Y; Ishii G; Nagai K; Ashimine S; Kuwata T; Hishida T; Nishimura M; Yoshida J; Takeyoshi I; Ochiai A
J Thorac Oncol; 2010 Oct; 5(10):1507-15. PubMed ID: 20802348
[TBL] [Abstract][Full Text] [Related]
40. The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones.
Kijima Y; Ishigami S; Hokita S; Koriyama C; Akiba S; Eizuru Y; Aikou T
Cancer Lett; 2003 Oct; 200(1):33-40. PubMed ID: 14550950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]